Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Auburn National Bancorp
AUBN
$91.9M
| $269K | ﹤0.01% |
12,641
+3,100
| +32% | +$64.7K |
|
|
EDN
3027
Edenor
EDN
$1.06B
| $269K | ﹤0.01% |
13,900
-28,200
| -67% | -$400K |
|
|
BRAG
3028
Bragg Gaming Group
BRAG
$51.8M
| $268K | ﹤0.01% |
53,095
+28,495
| +116% | +$138K |
|
3029
iShares Dow Jones US ETF
IYY
$3.06B
| $268K | ﹤0.01% |
2,300
-1,100
| -32% | -$120K |
|
3030
Pyxis Tankers
PXS
$51.5M
| $268K | ﹤0.01% |
64,317
-23,584
| -27% | -$92.5K |
|
3031
SGHC Ltd
SGHC
$6.63B
| $268K | ﹤0.01% |
+84,600
| New | +$284K |
|
3032
Escalade
ESCA
$311M
| $266K | ﹤0.01% |
13,230
+1,500
| +13% | +$27.7K |
|
3033
Renasant Corp
RNST
$3.91B
| $266K | ﹤0.01% |
7,900
-120,328
| -94% | -$3.37M |
|
3034
EVI Industries
EVI
$180M
| $265K | ﹤0.01% |
+11,165
| New | +$282K |
|
3035
Fidelity MSCI Health Care Index ETF
FHLC
$3.36B
| $265K | ﹤0.01% |
+4,100
| New | +$250K |
|
3036
Lisata Therapeutics
LSTA
$9.65M
| $265K | ﹤0.01% |
97,222
+1,500
| +2% | +$3.52K |
|
|
SCPH
3037
DELISTED
scPharmaceuticals
SCPH
| $263K | ﹤0.01% |
+41,900
| New | +$240K |
|
3038
MediciNova
MNOV
$66M
| $261K | ﹤0.01% |
174,100
+24,500
| +16% | +$44.3K |
|
|
OBE
3039
Obsidian Energy
OBE
$662M
| $261K | ﹤0.01% |
38,300
+22,600
| +144% | +$174K |
|
3040
Bluerock Homes Trust
BHM
$34.9M
| $260K | ﹤0.01% |
+18,600
| New | +$260K |
|
3041
Jerash Holdings
JRSH
$63.5M
| $258K | ﹤0.01% |
82,940
+6,700
| +9% | +$20.3K |
|
|
OCFT
3042
DELISTED
OneConnect Financial Technology
OCFT
| $258K | ﹤0.01% |
79,960
+300
| +0.4% | +$912 |
|
|
GPGI
3043
GPGI Inc
GPGI
$4.35B
| $257K | ﹤0.01% |
57,190
-22,635
| -28% | -$106K |
|
3044
CPS Technologies
CPSH
$86.1M
| $256K | ﹤0.01% |
108,858
+19,675
| +22% | +$48.8K |
|
3045
Lightbridge
LTBR
$311M
| $256K | ﹤0.01% |
+79,600
| New | +$317K |
|
3046
PrimeEnergy Resources
PNRG
$298M
| $255K | ﹤0.01% |
2,400
| – | – |
|
3047
Verastem
VSTM
$592M
| $255K | ﹤0.01% |
31,365
-15,000
| -32% | -$108K |
|
3048
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.36B
| $254K | ﹤0.01% |
+5,900
| New | +$235K |
|
3049
Aura Biosciences
AURA
$826M
| $253K | ﹤0.01% |
28,500
+15,000
| +111% | +$127K |
|
3050
Comtech Telecommunications
CMTL
$51.8M
| $253K | ﹤0.01% |
30,050
-76,200
| -72% | -$795K |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.